Loading…
Vivos Therapeutics, Inc. is projected to rise to $0.83 by 2027, a +26% move from its current price of $0.6611. VVOS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.6331 | $0.6611 | $0.6903 | -0.01% |
| May 30 | $0.6218 | $0.661 | $0.7027 | -0.01% |
| May 31 | $0.6133 | $0.661 | $0.7123 | -0.02% |
| Jun 1 | $0.6062 | $0.6609 | $0.7206 | -0.03% |
| Jun 2 | $0.60 | $0.6609 | $0.7279 | -0.04% |
| Jun 3 | $0.5944 | $0.6608 | $0.7346 | -0.04% |
| Jun 4 | $0.5894 | $0.6608 | $0.7408 | -0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.5894 | $0.6608 | $0.7408 | -0.05% |
| Week 2 | $0.5618 | $0.6604 | $0.7764 | -0.10% |
| Week 3 | $0.5415 | $0.6601 | $0.8047 | -0.16% |
| Week 4 | $0.5248 | $0.6597 | $0.8293 | -0.21% |
| Week 5 | $0.5106 | $0.6594 | $0.8515 | -0.26% |
| Week 6 | $0.498 | $0.659 | $0.8721 | -0.31% |
| Week 7 | $0.4867 | $0.6587 | $0.8915 | -0.36% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children.
The company markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. It was founded in 2016 and is based in Littleton, Colorado.
VVOS is the stock symbol for Vivos Therapeutics, Inc. It is currently trading at $0.6611 per share and has a market capitalization of $9.19M. It is ranked 5120 by market cap.
The 30-day price range is $0.4972 to $0.8791, reflecting recent trading activity within a narrow band.
The overall price outlook, as reflected in the year-by-year forecast, shows a neutral stance for 2026 with an average price of $0.6611, followed by bullish years in several later periods (e.g., 2027 avg $0.83, 2028 avg $0.8466, 2029 avg $0.8697, and stronger upside in later years such as 2040 avg $1.48 and 2050 avg $2.01). It is important to view these figures as estimates rather than guarantees.
A major floor 96.9% below — a decisive break under it would weaken the trend.
The nearest floor, 11.5% below — buyers have tended to step in here.
The nearest ceiling, 122.4% above — a clean break opens room to run.
A major ceiling 213.1% above — clearing it would confirm fresh momentum.
Key VVOS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VVOS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6186 | Buy | $0.6343 | Buy |
| MA 10 | $0.6324 | Buy | $0.6445 | Buy |
| MA 20 | $0.6818 | Sell | $0.7105 | Sell |
| MA 50 | $0.9648 | Sell | $0.9423 | Sell |
| MA 100 | $1.33 | Sell | $1.31 | Sell |
| MA 200 | $2.17 | Sell | $1.91 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.18 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -24.32 | Neutral |
| Williams %R (14) | -46.10 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | -0.60 | Sell |
| Bollinger %B (20,2) | 0.42 | Neutral |
| Stochastic %K (14) | 53.90 | Neutral |
| TRIX (15) | -1.93 | Sell |
| Awesome (5,34) | -0.22 | Sell |
| Ultimate (7,14,28) | 48.31 | Neutral |
| Momentum (10) | -0.06 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 0.63 | Buy |
| ADX (14) | 34.40 | Sell |
| ATR (14) | 0.03 | Info |
The technical picture is NEUTRAL at present. The RSI(14) stands at 40, indicating room for movement but not overbought conditions. The stock trades with the SMA50 at $0.9648 and the SMA200 at $2.17, suggesting the price is below the short- and long-term moving averages.
Support is identified at $0.585 and resistance at $1.47, offering limited downside and upside benchmarks in the near term. The 30-day range is $0.4972 to $0.8791, placing the current price of $0.6611 within that span and between the identified support and resistance levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.585 | $0.6611 | $0.9192 | 0% | Neutral | |
| $0.6211 | $0.83 | $1.19 | +26% | Bullish | |
| $0.6051 | $0.8466 | $1.28 | +28% | Bullish | |
| $0.5976 | $0.8697 | $1.37 | +32% | Bullish | |
| $0.5257 | $0.7924 | $1.29 | +20% | Neutral | |
| $0.4613 | $0.7185 | $1.21 | +9% | Neutral | |
| $0.5137 | $0.8253 | $1.42 | +25% | Bullish | |
| $0.5925 | $0.9804 | $1.73 | +48% | Bullish | |
| $0.6554 | $1.12 | $2.01 | +69% | Bullish | |
| $0.6187 | $1.08 | $1.99 | +64% | Bullish | |
| $0.7414 | $1.48 | $2.96 | +124% | Bullish | |
| $0.9053 | $2.01 | $4.53 | +204% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.585 | $0.6611 | $0.775 | +0.00% |
| June 2026 | $0.5269 | $0.6267 | $0.7689 | -5.20% |
| July 2026 | $0.5447 | $0.6567 | $0.8226 | +4.78% |
| August 2026 | $0.5555 | $0.6769 | $0.8615 | +3.08% |
| September 2026 | $0.5319 | $0.6538 | $0.8429 | -3.41% |
| October 2026 | $0.5357 | $0.6639 | $0.8659 | +1.54% |
| November 2026 | $0.5639 | $0.7039 | $0.9274 | +6.03% |
| December 2026 | $0.5498 | $0.6911 | $0.9192 | -1.83% |
Click any year to see its month-by-month VVOS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, VVOS could reach as high as $0.9192, with a base case around $0.6611 and support toward $0.585 — roughly 0% from $0.6611. A consolidation phase looks the most probable path here.
Expect VVOS to range from $0.6211 to $1.19 through 2027. The $0.83 average target implies a +26% move from current prices. That is up +26% on the projected 2026 average. Momentum favours further upside here.
The VVOS price prediction for 2028 points to an average of $0.8466 (low $0.6051, high $1.28) — a potential gain of +28% on today's $0.6611. Buyers look set to stay in control over this stretch.
In 2029, VVOS is projected to trade between $0.5976 and $1.37, averaging $0.8697 — a potential gain of +32% from today's $0.6611. That is up +3% on the projected 2028 average. Momentum favours further upside here.
Vivos Therapeutics, Inc.'s 2030 outlook centres on $0.7924, within a $0.5257 to $1.29 range. That is -9% versus the projected 2029 average. That marks a +20% change versus current levels. A consolidation phase looks the most probable path here.
By 2031, VVOS could reach as high as $1.21, with a base case around $0.7185 and support toward $0.4613 — roughly +9% from $0.6611. Price action looks broadly range-bound.
Expect VVOS to range from $0.5137 to $1.42 through 2032. The $0.8253 average target implies a +25% move from current prices. That is up +15% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The VVOS price prediction for 2033 points to an average of $0.9804 (low $0.5925, high $1.73) — a potential gain of +48% on today's $0.6611. Momentum favours further upside here.
In 2034, VVOS is projected to trade between $0.6554 and $2.01, averaging $1.12 — a potential gain of +69% from today's $0.6611. That is up +14% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Vivos Therapeutics, Inc.'s 2035 outlook centres on $1.08, within a $0.6187 to $1.99 range. That is -3% versus the projected 2034 average. That marks a +64% change versus current levels. Momentum favours further upside here.
By 2040, VVOS could reach as high as $2.96, with a base case around $1.48 and support toward $0.7414 — roughly +124% from $0.6611. Buyers look set to stay in control over this stretch.
Expect VVOS to range from $0.9053 to $4.53 through 2050. The $2.01 average target implies a +204% move from current prices. That is up +36% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in VVOS today (≈ 1,512.630464 VVOS) could be worth
$3,043.01
+$2,043.01 (+204%) by 2050 · US Dollar
Based on the average projected VVOS price of $2.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VVOSwould be worth at today's price.
$1,000 invested in VVOS on May 27, 2025 (≈ 440.528638 VVOS) would be worth
$291.23
-$708.77 (-70.9%) today · 0.29× · US Dollar
Based on a VVOS entry price of $2.27 vs. today's $0.6611.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.59 | $1,120.51 | +12.1% |
| 1 month ago | $0.863 | $766.05 | -23.4% |
| 3 months ago | $1.45 | $455.93 | -54.4% |
| 6 months ago | $2.26 | $292.52 | -70.7% |
| 1 year ago | $2.27 | $291.23 | -70.9% |
| All time (5.0y) ago | $133 | $4.97 | -99.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VVOS forecast.
Our base-case forecast reaches $1.30 around 2040.
Implied market cap at $1.30: $18.06M
The multi-year forecast outlines a path of gradual-to-accelerating appreciation. For 2026 the min is $0.585, the avg is $0.6611, and the max is $0.9192 with ROI 0 and sentiment NEUTRAL. In 2027 the avg rises to $0.83 with a max of $1.19, min $0.6211, ROI 25.6 and sentiment BULLISH.
In 2028 the avg is $0.8466, max $1.28, min $0.6051, ROI 28.1 and sentiment BULLISH, followed by 2029 with avg $0.8697, max $1.37, min $0.5976, ROI 31.6 and sentiment BULLISH.
The forecast continues with 2030 at avg $0.7924, min $0.5257, max $1.29, ROI 19.9 and sentiment NEUTRAL, and 2031 at avg $0.7185, min $0.4613, max $1.21, ROI 8.7 and sentiment NEUTRAL. In 2032 the avg rises to $0.8253, max $1.42, min $0.5137, ROI 24.8 and sentiment BULLISH, while 2033 shows avg $0.9804, max $1.73, min $0.5925, ROI 48.3 and sentiment BULLISH. 2034 carries an avg of $1.12, max $2.01, min $0.6554, ROI 68.8 and sentiment BULLISH, and 2035 has avg $1.08, max $1.99, min $0.6187, ROI 63.8 and sentiment BULLISH.
Looking further out, 2040 shows avg $1.48, max $2.96, min $0.7414, ROI 123.5 and sentiment BULLISH, while 2050 projects avg $2.01, max $4.53, min $0.9053, ROI 204.3 and sentiment BULLISH. These longer-horizon figures imply meaningful upside potential if the forecast materializes, alongside typical investment risks and uncertainties.
Tap a question to reveal the answer.
For 2030 the forecast shows min $0.5257, avg $0.7924, max $1.29, ROI 19.9 and sentiment NEUTRAL.
The 2033 forecast shows min $0.5925, avg $0.9804, max $1.73, ROI 48.3 and sentiment BULLISH.
Yes. The forecast includes bullish years such as 2027 (avg $0.83, ROI 25.6), 2028 (avg $0.8466, ROI 28.1), 2029 (avg $0.8697, ROI 31.6), and continues with bullish outlook in 2032–2035 and beyond (e.g., 2032 avg $0.8253, 2033 avg $0.9804, 2040 avg $1.48, 2050 avg $2.01).
The 30-day price range is $0.4972 to $0.8791.
The 2050 forecast lists min $0.9053, avg $2.01, max $4.53, ROI 204.3, sentiment BULLISH.
Vivos Therapeutics, Inc. Community Discussion
0Share your Vivos Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.